Neuro-Oncology Unit, Fondazione IRCCS Istituto Neurologico C. Besta, Via Celoria 11, 20133 Milan, Italy.
J Neurol Sci. 2013 Mar 15;326(1-2):115-9. doi: 10.1016/j.jns.2013.01.021. Epub 2013 Feb 9.
We report the clinical case of a 43year old Italian woman and her family with Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy (PLOSL), also known as Nasu-Hakola disease. PLOSL is a unique disease clinically characterized by a progressive presenile frontal-lobe dementia and multiple cystic bone lesions, typically leading to fractures of the limbs in the third decade of life. This rare recessively inherited disease is caused by mutations in one of two genes encoding different subunits of a receptor signalling complex, TYROBP and TREM2. In the present case fractures after microtrauma were not diagnosed, despite a radiological demonstration of the characteristic bone lesions in PLOSL. Further investigation led to the same diagnosis in her brother, with similar clinical presentation and the same mutation. Therefore a diagnosis of PLOSL should be considered in cases of presenile frontal-lobe dementia, even if the hallmark of pathological fractures is absent.
我们报告了一例 43 岁的意大利女性及其家族的临床病例,该家族患有多囊脂膜炎伴硬化性脑白质病(PLOSL),也称为 Nasu-Hakola 病。PLOSL 是一种独特的疾病,临床上以进行性早发性额叶痴呆和多发性囊性骨病变为特征,通常导致第三十年肢体骨折。这种罕见的隐性遗传性疾病是由编码受体信号复合物不同亚单位的两个基因之一的突变引起的,TYROBP 和 TREM2。在本病例中,尽管 PLOSL 存在特征性的骨病变,但在微创伤后未诊断出骨折。进一步的调查导致她的兄弟也有相同的诊断,其临床表现相似,且有相同的突变。因此,即使病理性骨折的特征不存在,也应考虑早发性额叶痴呆病例是否为 PLOSL。